Evidence map›Paper›PMID 27022110›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2016

Mammographic Density as a Biosensor of Tamoxifen Effectiveness in Adjuvant Endocrine Treatment of Breast Cancer: Opportunities and Implications.

Maeve Mullooly, Ruth M Pfeiffer, Sarah J Nyante, Brandy M Heckman-Stoddard, Marjorie Perloff, Ismail Jatoi, Louise A Brinton, Erin J Aiello Bowles, Robert N Hoover, Andrew Glass and 3 more

Abstract read
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Association between Participant Characteristics and Breast Parenchymal Texture Variation among Postmenopausal Women.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Ultrasound tomography imaging with waveform sound speed: Parenchymal changes in women undergoing tamoxifen therapy.Proceedings of SPIE--the International Society for Optical Engineering · 2017
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Maeve MulloolyNational Cancer Institute, Bethesda, MD maeve.mullooly@nih.gov.
Ruth M PfeifferNational Cancer Institute, Bethesda, MD.
Sarah J NyanteUniversity of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC.
Brandy M Heckman-StoddardNational Cancer Institute, Bethesda, MD.
Marjorie PerloffNational Cancer Institute, Bethesda, MD.
Ismail JatoiUniversity of Texas Health Science Center, San Antonio, TX.
Louise A BrintonNational Cancer Institute, Bethesda, MD.
Erin J Aiello BowlesGroup Health Research Institute, Seattle, WA.
Robert N HooverNational Cancer Institute, Bethesda, MD.
Andrew GlassKaiser Permanente Northwest Center for Health Research, Portland, OR.
Amy Berrington de GonzalezNational Cancer Institute, Bethesda, MD.
Mark E ShermanNational Cancer Institute, Bethesda, MD.
Gretchen L GierachNational Cancer Institute, Bethesda, MD.
Kaiser Permanente Washington Health Research Institute · USKaiser Permanente Center for Health Research · USNational Cancer Institute · USThe University of Texas Health Science Center at San Antonio · USUniversity of North Carolina at Chapel Hill · US

Funding

Hormone-Related CancersZIACP010126 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI GIERACH, GRETCHEN · 2009 to 2025
$103.5M
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biosensing TechniquesMammographyAntineoplastic Agents, HormonalBreast DensityBreast NeoplasmsChemotherapy, AdjuvantDisease-Free SurvivalDisease ProgressionDrug MonitoringFemaleHumansPredictive Value of TestsRisk FactorsTamoxifenTime FactorsTreatment OutcomeAntineoplastic Agents, HormonalTamoxifen

Identifiers

PMID27022110
PMCPMC4962703
OpenAlexW2323906109

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.